Menu
Recruiting NCT03690063

Nice Human Immunodeficiency Virus (HIV) Cohort

— Observational Human Immunodeficiency Virus

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Follow up.
Who it may be relevant to
Registry conditions: Human Immunodeficiency Virus. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Historically, the database on the HIV was organized within the framework of the medico-economic file of the human immunodeficiency (DMI-2), introduced jointly by the Direction of Hospitals (Mission AIDS) and the INSERM at the end of the 80s. Today this database is fed via the computerized medical record NADIS. Most part of the research works on the theme of the HIV take support on this database (DAD, EuroAIDS, Neuradapt).

Interventions

  • Other Follow up
    Follow up of treatment, behavior, co-morbidity

Primary outcome measures

  • change of the clinico-biological signs of the patients [Time frame: Each Year during 50 years]
Secondary outcome measures (1)
  • number of the various type of adverse events related by type of treatments [Time frame: Each Year during 50 years]

Eligibility criteria

Inclusion criteria

  • Enrol consecutive patients with a scheduled visit in the outpatient clinic (regardless of CD4 cell count and ART status).

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 1 center
  • CHU de Nice — Nice

Identifiers

NCT: NCT03690063 · 18-DSP-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗